← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2010Last known activity
Oct 31, 2022
Timeline
2000s
- Jun 1, 2001
Pieris Pharmaceuticals GmbH— Founded
Drugs by trial phase (10 distinct, 11 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT05473533Lead sponsorPhase 1Oct 31, 2022
- NCT05190445Lead sponsorPhase 2Nov 1, 2021
- NCT05190445Study directorPhase 2Nov 1, 2021
- NCT05159388Lead sponsorPhase 1/Phase 2Sep 8, 2021
- NCT05159388Study directorPhase 1/Phase 2Sep 8, 2021
- NCT03650348Study directorPhase 1Aug 21, 2018
- NCT03650348Lead sponsorPhase 1Aug 21, 2018
- NCT03574805Lead sponsorPhase 1Jul 18, 2018
- NCT03574805Study directorPhase 1Jul 18, 2018
- NCT03384290Study directorPhase 1Dec 20, 2017
- NCT03384290Lead sponsorPhase 1Dec 20, 2017
- NCT03325621Lead sponsorPhase 1/Phase 2Sep 30, 2017
- NCT03330561Study directorPhase 1Sep 28, 2017
- NCT03330561Lead sponsorPhase 1Sep 28, 2017
- NCT02754167Lead sponsorPhase 1/Phase 2Apr 1, 2016
Details
- Founded
- Boston, MA, US Jun 1, 2001
- Last known activity
- Oct 31, 2022